CD8A and lung cancer: The research demonstrates that CDEVs can serve not only as carriers for drug delivery, effectively loading chemotherapy drugs, but also correlate with downregulated PD-L1 expression, which may enhance the killing function of immune-infiltrating CD8+ T cells in lung cancer[36,39].